Citation Tools
PDFRegular and young investigator award abstracts
Combination immunotherapies
473 Mavrilimumab, a human monoclonal antibody targeting GM-CSFRα, inhibits polarization to myeloid-derived suppressor cells (MDSCs) that express PD-L1 and restores T-cell proliferation in vitro
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 473 Mavrilimumab, a human monoclonal antibody targeting GM-CSFRα, inhibits polarization to myeloid-derived suppressor cells (MDSCs) that express PD-L1 and restores T-cell proliferation in vitro